{"nctId":"NCT00168428","briefTitle":"A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches","startDateStruct":{"date":"2006-03"},"conditions":["Migraine Disorders"],"count":705,"armGroups":[{"label":"botulinum toxin Type A","type":"EXPERIMENTAL","interventionNames":["Biological: Botulinum Toxin Type A"]},{"label":"Placebo (saline)","type":"PLACEBO_COMPARATOR","interventionNames":["Other: placebo (saline)"]}],"interventions":[{"name":"Botulinum Toxin Type A","otherNames":["BOTOXÂ®"]},{"name":"placebo (saline)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Frequent migraine (\\>=15 headache days per month)\n* \\>=4 distinct headache episodes lasting \\>=4 hours\n* \\>=50% of baseline headache days migraine/probable migraine days\n\nExclusion Criteria:\n\n* Previous use of botulinum toxin of any serotype or immunization to any botulinum toxin serotype\n* Any medical condition that puts the patient at increased risk with exposure to BOTOX\n* Diagnosis of complicated migraine, chronic tension-type headache, hypnic headache, hemicrania continua, new daily persistent headache\n* Use of prophylactic headache medication within 28 days prior to week -4\n* Unremitting headache lasting continuously throughout the 4-week baseline period\n* Known or suspected TMD\n* Diagnosis of fibromyalgia\n* Beck depression inventory score \\>24 at week-4\n* Psychiatric problems that may have interfered with study participation","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Frequency of Headache Days","description":"Mean change from baseline in frequency (number) of headache days during the 28 day period ending with Week 24. Headache day defined as a calendar day \\[00:00 to 23:59\\] for which the patient reported \\>= 4 continuous hours of headache.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.9","spread":"3.63"},{"groupId":"OG001","value":"19.7","spread":"3.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-9.0","spread":"6.54"},{"groupId":"OG001","value":"-6.7","spread":"6.67"}]}]}]},{"type":"SECONDARY","title":"Change in Total Cumulative Hours of Headache Occurring on Headache Days","description":"Mean change from baseline in total cumulative hours of headache occurring on headache days during the 28 day period ending with Week 24. Headache day defined as a calendar day \\[00:00 to 23:59\\] when the patient reported \\>= 4 continuous hours of headache.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"296.18","spread":"121.043"},{"groupId":"OG001","value":"287.20","spread":"118.089"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-132.41","spread":"130.216"},{"groupId":"OG001","value":"-90.01","spread":"133.758"}]}]}]},{"type":"SECONDARY","title":"Change in Frequency of Moderate/Severe Headache Days","description":"Mean change from baseline in frequency (number) of moderate/severe headache days during the 28 day period ending with Week 24. Those calendar days with \\>= 4 continuous hours of headache were selected. As per the patient diary, all headache episodes occurring during those days with a maximum severity of moderate or severe were counted.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.1","spread":"4.03"},{"groupId":"OG001","value":"17.7","spread":"4.26"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.3","spread":"6.37"},{"groupId":"OG001","value":"-5.8","spread":"6.59"}]}]}]},{"type":"SECONDARY","title":"Change in Frequency of Migraine/Probable Migraine Headache Days","description":"Mean change from baseline in frequency (number) of migraine/probable migraine headache days during the 28 day period ending with Week 24. Headache day defined as a calendar day with \\>= 4 continuous hours of headache meeting the ICHD-II criteria for migraine or probable migraine.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.2","spread":"3.94"},{"groupId":"OG001","value":"18.7","spread":"4.05"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.7","spread":"6.64"},{"groupId":"OG001","value":"-6.3","spread":"6.71"}]}]}]},{"type":"SECONDARY","title":"Change in Frequency of Headache Episodes","description":"Mean change from baseline in frequency (number) of headache episodes during the 28 day period ending with Week 24. Headache episode defined as patient-reported headache with a start and stop time indicating that the pain lasted \\>= 4 continuous hours.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.0","spread":"5.27"},{"groupId":"OG001","value":"12.7","spread":"5.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.3","spread":"5.12"},{"groupId":"OG001","value":"-4.6","spread":"4.84"}]}]}]},{"type":"SECONDARY","title":"Percentage of Patients With Severe HIT-6 Impact Category Scores","description":"Percentage of patients with a severe (60-78) score on the Headache Impact Test (HIT-6) Questionnaire during the 28 day period, ending with Week 24. The HIT-6 consisted of 6 questions about headache and impact on the patient's health and well-being. Answers for each question ranged from 6=Never, 8=Rarely, 10=Sometimes, 11=Very Often, and 13=Always. The total scores ranged from 36-49 (Little or No Impact), 50-55 (Some Impact), 56-59 (Substantial Impact) and 60-78 (Severe Impact).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"66.3","spread":null},{"groupId":"OG001","value":"76.5","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":33,"n":676},"commonTop":["Neck pain","Nasopharyngitis","Sinusitis","Muscular weakness"]}}}